Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery

Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow–derived cells (BMCs) and decellularized tissue matric...

Full description

Bibliographic Details
Main Authors: Cho, Seung Woo, Kim, Il-Kwon, Kang, Jin Muk, Song, Kang Won, Kim, Hong Sik, Park, Chang Hwan, Yoo, Kyung Jong, Kim, Byung-Soo
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering
Format: Article
Language:en_US
Published: Mary Ann Liebert 2011
Online Access:http://hdl.handle.net/1721.1/61684
_version_ 1826205025596080128
author Cho, Seung Woo
Kim, Il-Kwon
Kang, Jin Muk
Song, Kang Won
Kim, Hong Sik
Park, Chang Hwan
Yoo, Kyung Jong
Kim, Byung-Soo
author2 Massachusetts Institute of Technology. Department of Chemical Engineering
author_facet Massachusetts Institute of Technology. Department of Chemical Engineering
Cho, Seung Woo
Kim, Il-Kwon
Kang, Jin Muk
Song, Kang Won
Kim, Hong Sik
Park, Chang Hwan
Yoo, Kyung Jong
Kim, Byung-Soo
author_sort Cho, Seung Woo
collection MIT
description Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow–derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle–like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n¼4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription–polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.
first_indexed 2024-09-23T13:05:34Z
format Article
id mit-1721.1/61684
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T13:05:34Z
publishDate 2011
publisher Mary Ann Liebert
record_format dspace
spelling mit-1721.1/616842022-09-28T11:58:06Z Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery Cho, Seung Woo Kim, Il-Kwon Kang, Jin Muk Song, Kang Won Kim, Hong Sik Park, Chang Hwan Yoo, Kyung Jong Kim, Byung-Soo Massachusetts Institute of Technology. Department of Chemical Engineering Cho, Seung Woo Cho, Seung Woo Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow–derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle–like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n¼4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription–polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery. Korea. Ministry of Health and Welfare (Grant A050082) (Grant 02-PJ10- PG8-EC01-0016) 2011-03-11T21:05:48Z 2011-03-11T21:05:48Z 2008-09 Article http://purl.org/eprint/type/JournalArticle 1937-3341 1937-335X http://hdl.handle.net/1721.1/61684 Cho, Seung-Woo et al. "Evidence for <i>In Vivo</i> Growth Potential and Vascular Remodeling of Tissue-Engineered Artery." Tissue Engineering Part A 15.4 (2009): 901-912. © 2009, Mary Ann Liebert, Inc. en_US http://dx.doi.org/10.1089/ten.tea.2008.0172 Tissue Engineering. Part A Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf Mary Ann Liebert Mary Ann Liebert
spellingShingle Cho, Seung Woo
Kim, Il-Kwon
Kang, Jin Muk
Song, Kang Won
Kim, Hong Sik
Park, Chang Hwan
Yoo, Kyung Jong
Kim, Byung-Soo
Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title_full Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title_fullStr Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title_full_unstemmed Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title_short Evidence for In Vivo Growth Potential and Vascular Remodeling of Tissue-Engineered Artery
title_sort evidence for in vivo growth potential and vascular remodeling of tissue engineered artery
url http://hdl.handle.net/1721.1/61684
work_keys_str_mv AT choseungwoo evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT kimilkwon evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT kangjinmuk evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT songkangwon evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT kimhongsik evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT parkchanghwan evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT yookyungjong evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery
AT kimbyungsoo evidenceforinvivogrowthpotentialandvascularremodelingoftissueengineeredartery